Galmed Pharmaceutica (GLMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Sales | 0 | 2,038 | 1,085 | 467 | 0 |
| Gross Profit | N/A | 2,038 | 1,085 | 467 | N/A |
| Operating Expenses | 22,376 | 12,753 | 13,449 | 17,349 | 10,875 |
| Operating Income | -22,376 | -10,715 | -12,364 | -16,882 | -10,875 |
| Other Income | 1,915 | 934 | 65 | 35 | 253 |
| Pre-tax Income | -20,461 | -9,781 | -12,299 | -16,847 | -10,622 |
| Income Tax | N/A | 75 | N/A | 106 | N/A |
| Net Income Continuous | -20,461 | -9,856 | -12,299 | -16,953 | -10,622 |
| Net Income | $-20,461 | $-9,856 | $-12,299 | $-16,953 | $-10,622 |
| EPS Basic Total Ops | -174.58 | -97.19 | -176.38 | -268.17 | -172.78 |
| EPS Basic Continuous Ops | -174.41 | -97.80 | -177.27 | -268.24 | -172.23 |
| EPS Diluted Total Ops | -174.58 | -97.19 | -176.38 | -268.17 | -172.78 |
| EPS Diluted Continuous Ops | -174.41 | -97.80 | -177.27 | -268.24 | -172.23 |
| EPS Diluted Before Non-Recurring Items | -174.58 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-22,446 | $-10,472 | $-12,104 | $-16,669 | $-10,733 |